Massachusetts Institute of Technology

Massachusetts Institute of Technology

Massachusetts Institute of Technology

Date Founded



77 Massachusetts Avenue, Cambridge, MA, 02139, USA

Employees (Worldwide)



Market & Policy Research
Schools & Student Services

Company Description

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

In The News
Subscribe now to see full news coverage
Executives & Employees

Manager Owner

Chief Executive Officer & Managing Partner, MIT the Engine Fund

Managing Partner


Executive Director of Communications, Resource Development

Executive Director for Foundation Relations, Resource Development

Executive Director Designx

Executive Director for Research

Executive Director

Subscribe now to see full list of current and former executives
Board of Directors

Former Managing Director at Barclays Capital, Inc.

Partner Emeritus at Polaris Partners

Founder at Calico LLC

Founder at InterSystems Corporation

President at Harvard University

Board of Trustees & Dean's Advisory Council Member at Massachusetts Institute of Technology

Chairman & Chief Executive Officer at Redseal, Inc.

Subscribe now to see full list of current and former board members
Distinguished Alumni
Irwin Mark Jacobs is now Co-Founder at Qualcomm, Inc.
Wes Bush is now Chairman of the Board & Chief Executive Officer at Northrop Grumman Corp.
Subscribe now to see full list of distinguished alumni
Paths to Massachusetts Institute of Technology
Potential Connections via
Relationship Science
Massachusetts Institute of Technology
Advisors & Consultants

TSD helps companies, campaigns, and causes communicate clearly and effectively. The organization design strategic communications plans and offer a full portfolio of related services: crisis communications, litigation and regulatory support, communications reviews, speechwriting and media training.

Subscribe now to see advisors & consultants for over 2.5 million organizations
Legal Advisor

Partner at Irell & Manella LLP

Visiting Professor of the Practice at Duke University - Sanford School of Public Policy

Legal Advisor

Practice Group Co-Leader, Intellectual Property at Troutman Sanders LLP

Subscribe now to see 12+ more consultants & advisors

If you've ever shopped online, downloaded music, watched a web video or connected to work remotely, you've probably used Akamai's cloud platform. We ensure the best online experience on any device, anywhere. Akamai helps enterprises accelerate innovation in the hyperconnected world by removing the complexities of technology so you can focus on driving your business faster forward. We enable enterprises to capitalize on market opportunities presented by trends like mobile and cloud while overcoming the challenges presented by security threats and the need to reach users globally. The Akamai Intelligent Platform™ reaches globally and delivers locally, providing our customers with unmatched reliability, security and visibility into their online business

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Momenta is a leader in the analysis, characterization, and design of complex pharmaceutical products. Our scientific foundation is a set of tools and methods that enable one to develop a deep understanding of the links between a compound’s chemical structure, its manufacturing process and its biological function. These innovative tools enable us to develop complex generics and follow-on biologics as well as facilitate the discovery of novel drugs. We believe that by applying our innovative technology to our discovery and development programs, we have the potential to create a robust pipeline of innovative generic and novel drugs. Our success is a result of our committed and talented people. We attract scientists exceptionally skilled in integrating information from diverse technical disciplines and task them with challenging characterization, process, and biology problems. Using this approach, we have designed tools and methods to understand the structure (characterization of chemical components), structure-process (design and control of manufacturing process) and structure-activity (relationships between structure and biological and clinical activity) of complex mixture drugs. From this knowledge comes a diversified product development pipeline consisting of both generic and novel complex mixture drugs designed to address a variety of medical needs. In July 2010, Momenta announced the FDA approval of our first drug, enoxaparin sodium injection developed in collaboration with Sandoz. Enoxaparin is a more affordable, generic version of Lovenox® (enoxaparin sodium injection), which is indicated for the prophylaxis of deep vein thrombosis (DVT). Enoxaparin sodium injection is a heparin-based complex mixture drug that was developed using our innovative scientific approach. Following this initial success, we are applying a similar approach to developing a generic version of Copaxone® (glatiramer acetate), a complex mixture of polypeptides indicated for the treatment of relapsing-remitting multiple sclerosis. We are also adding follow-on biologics, which are highly similar and potentially interchangeable biologics, to our development pipeline. And finally, with the knowledge acquired from our complex generic and follow-on biologics business, we are our using our tools and technology to design and improve the structures of proteins and heparin-derived products to create novel drugs

Subscribe now to see 17 more clients
Subscribe now to see clients for over 2.5 million organizations
Key Stats and Financials As of 2016
Market Capitalization
Total Enterprise Value
Earnings Per Share
Subscribe now to see full financial details
Non-Profit Donations & Grants
Subscribe now to see 47 more non-profit donations & grants
Non-Profit Donations & Grants Received
Subscribe now to see 47 more non-profit donations & grants
Details Hidden
Details Hidden
Details Hidden

Play Labs LLC is a company headquartered in Cambridge, MA, that acts as an alternative investment manager.

Subscribe now to see full investment details
Harvard Bioscience, Inc. Industrial Machinery & Manufacturing | Holliston, MA

Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

TEK Microsystems, Inc. IT Consulting & Services | Chelmsford, MA

TEK Microsystems, Inc. designs, manufactures and markets field-programmable gate array based sensor I/O processing products. The company was founded by Andrew Reddig and Kirian Reddig in November 1981 and is headquartered in Chelmsford, MA.

Alexandria Real Estate Equities, Inc. Real Estate Investment Trusts | Pasadena, CA

Alexandria Real Estate Equities, Inc. operates as a real estate investment trust, which engages in the development through ownership, operation, management, selective acquisition, development, and redevelopment of properties containing life science laboratory space. It also provides real estate, technical infrastructure, and services to the diverse life science industry. The company was founded by Joel S. Marcus and Jerry M. Sudarsky in June 1994 and is headquartered in Pasadena, CA.

Subscribe now to see 14 more suppliers
Awards & Honors
Rank #47
The Chronicle of Philanthropy - Philanthropy 400
Rank #50
The Chronicle of Philanthropy - Philanthropy 400